3 ASX 200 stocks to buy and hold forever without thinking twice

Here's why these shares could be great buy and hold options for investors.

| More on:
A man points at a paper as he holds an alarm clock.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

When it comes to building lasting wealth, few strategies are as powerful — or as simple — as buy and hold investing.

Instead of trying to time the market or jump in and out of ASX 200 stocks based on the latest headlines, buy and hold investors focus on finding great businesses, backing them with confidence, and letting time do the hard work.

However, not every stock is suited to a forever portfolio. The key is choosing companies with sustainable competitive advantages, strong balance sheets, positive long term growth outlooks, and talented management teams.

With that in mind, let's look at three ASX 200 stocks that I believe fit that description perfectly — companies you could buy today and hold forever without thinking twice. They are as follows:

CSL Ltd (ASX: CSL)

First up is CSL. It is one of Australia's greatest corporate success stories.

CSL is a global leader in plasma therapies, vaccines, and kidney disease treatments, with operations across the globe and a history stretching back over a century.

What makes CSL such a powerful buy and hold candidate is its incredible moat. Collecting plasma at scale, processing it efficiently, and developing specialised therapies is no easy feat. CSL's infrastructure, regulatory expertise, and relationships with healthcare providers create massive barriers to entry.

And with the company tipped to go through a period of strong earnings growth and its shares still down in the dumps, now could be the perfect time to invest. Goldman Sachs thinks this is the case. It has put a buy rating and $307.30 price target on its shares.

Pro Medicus Ltd (ASX: PME)

Another ASX 200 stock to buy and hold is Pro Medicus. It is a health imaging software specialist that is rapidly becoming a global powerhouse.

Its flagship product, Visage, is used by leading hospitals and healthcare networks to manage and interpret massive volumes of diagnostic images faster and more efficiently than traditional systems.

What sets Pro Medicus apart is its razor-sharp focus on premium technology and its highly scalable, high-margin software-as-a-service (SaaS) business model. Once a major hospital network signs up, switching costs are significant, locking customers in for the long term and creating incredibly sticky recurring revenue.

Goldman Sachs is also very positive on this stock. It has a buy rating and $309.00 price target on its shares.

WiseTech Global Ltd (ASX: WTC)

The third ASX 200 stock that I would happily buy and hold forever is WiseTech Global.

It is the company behind CargoWise, a logistics software platform used by some of the biggest freight forwarders and transport businesses in the world. As global trade becomes more complex and supply chains grow ever more intricate, demand for efficient digital logistics solutions is only going to increase — and WiseTech is perfectly positioned to capitalise.

One of WiseTech's greatest strengths is its dominant market position. CargoWise has become the gold standard in freight management software, and the company's relentless focus on innovation, integration, and global expansion continues to pay off. This bodes well for its long term growth.

Analysts at Macquarie are very positive on the company. They have an outperform rating and $152.70 price target on its shares.

Motley Fool contributor James Mickleboro has positions in CSL, Pro Medicus, and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Goldman Sachs Group, Macquarie Group, and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Macquarie Group and WiseTech Global. The Motley Fool Australia has recommended CSL and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Growth Shares

Where to invest $1,000 into ASX shares in June

These shares could be buys according to analysts.

Read more »

Young female investor smiling and speaking on mobile phone while sitting in front of laptop
Growth Shares

Looking for ASX growth shares? I rate these 2 as top buys for June

I’m very excited about the growth potential of these stocks…

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Growth Shares

3 high-conviction ASX growth shares to buy

Analysts have good things to say about these stocks.

Read more »

happy investor, share price rise, increase, up
Growth Shares

Where to invest $5,000 into ASX growth shares now

These shares could be destined for big things according to analysts.

Read more »

ETF spelt out with a piggybank.
ETFs

Want to buy ASX growth shares? Consider these ETFs instead

Growth ETFs can be easier to invest in than shares.

Read more »

A businessman compares the growth trajectory of property versus shares.
Growth Shares

Are these 2 top ASX growth shares buys?

ASX growth shares can deliver strong results. Should these stocks be in your portfolio?

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Growth Shares

These ASX growth stocks could rise 80% to 100%

Let's see what brokers are tipping as buys with big return potential.

Read more »

Man holding a tray of burritos, symbolising the Guzman share price.
Share Market News

Wingstop mania hits Sydney — is Guzman y Gomez next in line to soar?

Can Guzman y Gomez be Australia’s next fast food success story on the ASX?

Read more »